I Have Reviewed Over 1000 Supplement Formulations. Here Is Why 95% of Sleep Products Don't Work.

Let me tell you something that the sleep supplement industry would prefer you did not know.

The ingredients on most sleep supplement labels are real. The research behind most of those ingredients is legitimate. The doses on the label are the problem — and the gap between what is on the label and what actually works is where an $18 billion global industry is quietly pocketing the difference.

I have been on the formulation side of this industry for over twenty years. I have reviewed more supplement briefs, ingredient dossiers, and finished product specifications than I can accurately count. I know how products are built, why they are built the way they are, and what the incentive structures look like that produce a market where a consumer can spend years trying sleep supplements and never once encounter one that was dosed to work.

This is the article I wish someone had published when I started.

How a Sleep Supplement Is Actually Built

When a supplement company decides to launch a sleep product, the process typically starts with a COGS target — cost of goods sold — not a clinical brief. The marketing team identifies the category opportunity. The finance team sets the margin requirement. The formulator is handed a budget and told to build something that fits inside it.

Within that budget, the formulator makes choices. Popular ingredients go on the label because consumers recognise them. Expensive ingredients get cut or their doses get reduced until they fit the number. The proprietary blend exists — in nine out of ten cases — not to protect intellectual property but to hide the fact that the individual ingredient doses are too low to appear credible on a transparent label.

Industry consultant Blake Ebersole described the use of proprietary blends as "typically lazy and pretentious," adding that brands often use them to create the appearance of intellectual property when they have no real competitive advantage in their formulation.

This is not a fringe problem. The sleep supplement market was valued at USD 18.2 billion in 2024, with melatonin holding the largest market share at 42%. That is an enormous volume of product moving through the market, the majority of it formulated to a price point rather than a clinical standard.

What Pixie Dusting Looks Like in Practice

Pixie dusting is the industry term for including an ingredient at a dose too low to produce any meaningful physiological effect. A supplement might list a beneficial ingredient known for enhancing a specific outcome, while the product actually contains only a fraction of the amount necessary to be effective, hidden behind a proprietary blend.

Here is a concrete example from the sleep category. L-theanine has a well-established clinical literature for sleep quality improvement. A 2025 meta-analysis across 19 randomised controlled trials confirmed significant improvements in sleep onset latency and daytime dysfunction at 200mg. Some popular beverage and supplement products have been found to contain as little as 25 to 50mg of L-theanine — which is unlikely to have a discernible impact on stress levels or sleep quality.

The consumer reads "L-theanine" on the label. The consumer associates L-theanine with sleep support. The consumer does not know that 25mg and 200mg are not the same product in any clinically meaningful sense. The company knows this. The dose is chosen accordingly.

I have reviewed products containing glycine for sleep at 300mg. The polysomnographic trials that confirmed reduced sleep onset latency used 3000mg — ten times that dose. The mechanism by which glycine improves sleep onset (peripheral vasodilation triggering the core body temperature drop required for sleep) does not engage at 300mg in any consistent, documented way. At 3000mg it works on night one. The difference between 300mg and 3000mg on a label is three zeros. The difference in cost of goods is significant. The difference in consumer outcome is the reason most people who try sleep supplements conclude they don't work.

The Melatonin Problem

Melatonin deserves its own discussion because it is both the most widely used sleep supplement ingredient and, in my professional assessment, the most commonly misapplied one.

Melatonin is a hormone that signals the onset of sleep. It tells the brain that darkness has arrived and sleep should begin. This is a real and documented mechanism. The problem is what melatonin does not do.

Melatonin does not lower cortisol. It does not facilitate the brainwave transition from beta to alpha. It does not trigger the core body temperature drop required for sleep onset. It does not sustain GABAergic inhibitory tone through the sleep cycle. It does not support deep slow wave sleep architecture.

For a man over 30 dealing with elevated evening cortisol, a nervous system locked in operational mode, and five years of progressive sleep deterioration, melatonin is addressing the most superficial layer of a multi-layer problem. It signals sleep onset into a physiological environment that is not ready to receive that signal — which is why so many melatonin users fall asleep initially and wake up two hours later more alert than when they started.

There is also a longer-term concern that the industry does not advertise. Chronic exogenous melatonin supplementation at doses common in the consumer market (3mg to 10mg, when research supports 0.5mg to 1mg for most applications) may suppress endogenous melatonin production over time. You are training your body to rely on an external source for a hormone it should be producing itself. This is not a theoretical concern. It is the same feedback mechanism that makes pharmaceutical sleep aids progressively less effective over time.

Wulf Sleep contains no melatonin. Not because we could not include it. Because the formulation brief was built around what actually produces restorative sleep, and melatonin is not the answer to the question we were trying to solve.

What a Clinical Formulation Brief Looks Like

When I built Wulf Sleep, the process started differently. The brief was the sleep physiology — the specific cascade of events that needs to occur for a man to fall asleep, stay asleep, achieve adequate slow wave depth, and wake genuinely restored. Every ingredient decision was made relative to that cascade.

Sleep onset requires a core body temperature drop. Which ingredient facilitates that? Glycine at 3000mg, via peripheral vasodilation. That is in the formulation at that dose.

Sleep onset requires the nervous system to transition from beta wave dominance to alpha wave relaxation. Which ingredients facilitate that? PharmaGABA™ at 130mg — naturally fermented, EEG-confirmed — and L-theanine at 200mg, working synergistically on the brainwave transition. Both in the formulation at clinical doses.

The most common cause of sleep maintenance failure in men over 30 is elevated evening cortisol that does not follow its normal decline curve. Which ingredient addresses cortisol specifically? Lactium® — alpha-casozepine — at 200mg, binding to the GABA-A receptor and directly reducing HPA axis activity. In the formulation at the dose used in placebo-controlled clinical trials.

GABA tone needs to persist through the sleep cycle, not just at sleep onset. Which ingredients support GABA persistence? Lemon Balm at 200mg (5% rosmarinic acid) inhibiting GABA transaminase — the enzyme that breaks GABA down — extending inhibitory signalling through the night. In the formulation at that standardisation.

Slow wave sleep quality depends on magnesium status and GABA-A receptor function. Which form of magnesium maximises both? Magnesium Glycinate — chelated, genuinely bioavailable, not oxide. At 1650mg. In the formulation.

Every single ingredient decision had a mechanism behind it and a clinical dose to support it. The COGS target came after the formulation brief, not before. The price of the product reflects that sequence.

What We Tested and Removed — And Why

This is the part of the formulation story that most brands never tell you, because most brands never actually run this process.

The original Wulf Sleep formula contained three ingredients that did not make the final product: Magnesium Threonate, Inositol, and Tryptophan. All three have legitimate sleep-related research behind them. All three were removed after testing revealed an excitatory response in a subset of participants — the opposite of the intended effect.

Magnesium Threonate is often cited as the superior form of magnesium for cognitive applications because it crosses the blood-brain barrier more readily than other forms. That same property — enhanced central nervous system penetration — is what caused problems in testing. In some individuals, increased neuronal magnesium activity produced stimulation rather than sedation, extending sleep onset rather than shortening it. For a sleep formula where the entire architecture depends on reducing neuronal excitability, this was an unacceptable risk in a population-level product.

Inositol has a complex relationship with neurotransmitter pathways. At the doses used in anxiety and sleep research, it can have a calming effect for some individuals. In others — particularly those with certain serotonergic profiles — it produces a stimulating response. The inconsistency across our test group was sufficient to remove it. A sleep supplement that works for 70% of users and activates the other 30% is not a sleep supplement. It is a variable outcome.

Tryptophan is the amino acid precursor to both serotonin and melatonin. The intended pathway is: tryptophan converts to serotonin, serotonin converts to melatonin, sleep follows. The problem is that conversion does not always proceed cleanly along that pathway. In men with already-adequate serotonin tone — which describes a significant proportion of the target demographic — tryptophan supplementation can produce an alerting serotonergic effect rather than a sedative one. We observed this in testing. The ingredient was removed.

The decision to cut three ingredients with genuine research support behind them — based on observed excitatory responses in a testing cohort — is not a decision driven by cost reduction. Magnesium Threonate in particular is more expensive than the Magnesium Glycinate that replaced it in the final formula. These were clinical decisions. The product that reaches you is not the first version we built. It is the version that survived testing.

This is what a real formulation process looks like. Not every brand runs one.

How to Read a Sleep Supplement Label

If you are evaluating any sleep supplement — including ours — here is what to look for.

Transparent dosing. Every ingredient should be listed with its individual dose. If you see a "Proprietary Sleep Blend 800mg" containing six ingredients, you cannot know whether any single ingredient is present at a meaningful dose. With a 460mg blend containing 14 ingredients, you are down to roughly 33mg per ingredient — firmly in pixie dusting territory. Walk away.

Standardised botanical extracts. An herb listed as "chamomile extract" tells you very little. "Chamomile Extract standardised to 3.2% apigenin" tells you the active compound — the apigenin flavonoid responsible for GABA-A receptor binding — is present and quantified. Standardisation is the difference between a consistent therapeutic dose and an unknown quantity of plant material.

Form specificity for minerals. Magnesium oxide and magnesium glycinate are not the same ingredient. Neither are zinc oxide and zinc bisglycinate. The chelated forms have dramatically superior bioavailability and meaningfully different clinical outcomes. A label that does not specify the form is almost certainly using the cheap form.

Dose versus clinical reference. Before trusting any ingredient inclusion, look up the dose used in the trials that produced the positive outcome you are expecting. If the label dose is a fraction of the trial dose, the mechanism will not engage reliably. The ingredient is on the label. The effect is not in the capsule.

Named versus generic branded ingredients. PharmaGABA™ is not the same as GABA. Lactium® is not the same as milk protein hydrolysate. These are patented, clinically researched forms of their ingredients. When you see the branded name with the trademark symbol, you know you are getting the form the research was conducted on. When you see the generic name, you may or may not be.

Why Most Sleep Supplements Fail the People Using Them

The sleep supplement market has an enormous population of frustrated former customers — people who tried magnesium, melatonin, valerian, ashwagandha, ZMA, herbal blends, and combination products, and whose sleep problem remained essentially unchanged. Those people do not conclude that the products were underdosed. They conclude that supplements don't work, or that their sleep problem is unfixable, or that they simply need to accept a deteriorating night's rest as part of getting older.

This conclusion is wrong, but the industry produced it. The pattern of deception has gone largely unnoticed and unchecked for years, leaving the trusting customer at the mercy of brands that prioritise marketing hype over clinical outcomes.

The sleep problem most men over 30 are dealing with is physiological, predictable, and addressable. Elevated evening cortisol. Insufficient GABAergic tone. Impaired sleep onset temperature drop. Disrupted slow wave architecture. These are not mysteries. They are documented mechanisms with documented solutions.

The solutions require the right ingredients at the right doses in the right forms, formulated around the physiology rather than the margin.

That is what Wulf Sleep is. Not because we have access to ingredients others don't. Because we ran a formulation process that most brands don't — starting with the clinical brief and building the product around it rather than the other way around.

If you have tried sleep supplements before and been disappointed, I would ask you to look at the doses before concluding the category does not work. The category works. Most of what is in it does not.

The Performance Stack: Both Ends of the Loop

Sleep in isolation is only half the problem for most men dealing with the wired-tired loop. Poor sleep suppresses testosterone. Low testosterone impairs sleep quality. The loop runs in both directions and requires pressure at both ends simultaneously.

The Performance Stack was built on the same formulation philosophy — Wulf Sleep for the night, Wulf Test for the day, every ingredient in both products dosed where the clinical research lives. If you want to understand the formulation rationale for Wulf Test in the same detail, that is the subject of a separate article in this series.

But the short version is this: we applied the same brief to testosterone support that we applied to sleep. Start with the physiology. Identify the mechanisms. Find the ingredients with clinical evidence for those mechanisms. Dose them correctly. Build the product last.

It is a slower and more expensive way to formulate. It produces a different result.

The Mr Wulf Men formulator series continues with: Why I Refused to Put Melatonin in Wulf Sleep.